Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fimmu.2021.704110 http://scihub22266oqcxt.onion/10.3389/fimmu.2021.704110 34447374!8383886!34447374     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Immunol 2021 ; 12 (ä): 704110 Nephropedia Template TP {{tp|p=34447374|t=2021. COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial |pdf=|usr=}}{{34447374}} gab.com Text COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial JO: Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34447374 #FOAvip Patients diagnosed with malignancy, neurological and immunological disorders, i.e., fragile patients, have been excluded from COVID-19 vaccine trials. However, this population may present immune response abnormalities, and relative reduced vaccine responsiveness. Here we review the limited current evidence on the immune responses to vaccination of patients with different underlying diseases. To address open questions we present the VAX4FRAIL study aimed at assessing immune responses to vaccination in a large transdisease cohort of patients with cancer, neurological and rheumatological diseases. Twit Text FOAVip COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial ????Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34447374 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34447374 #FOAvip English Wikipedia <ref>{{Cite pmid|34447374}}</ref> COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial #MMPMID34447374 Agrati C; Di Cosimo S; Fenoglio D; Apolone G; Ciceri F; Ciliberto G; Baldanti F; Costantini M; Giannarelli D; Ippolito G; Locatelli F; Mantovani A; Morrone A; Tagliavini F; Uccelli A; Zinzani PL; Silvestris N; Rescigno M Front Immunol 2021[]; 12 (ä): 704110 PMID34447374show ga Patients diagnosed with malignancy, neurological and immunological disorders, i.e., fragile patients, have been excluded from COVID-19 vaccine trials. However, this population may present immune response abnormalities, and relative reduced vaccine responsiveness. Here we review the limited current evidence on the immune responses to vaccination of patients with different underlying diseases. To address open questions we present the VAX4FRAIL study aimed at assessing immune responses to vaccination in a large transdisease cohort of patients with cancer, neurological and rheumatological diseases. |Adult[MESH] |COVID-19 Vaccines/*administration & dosage/immunology[MESH] |Clinical Protocols[MESH] |Humans[MESH] |Immune System Diseases/immunology[MESH] |Immunocompromised Host/immunology[MESH] |Neoplasms/immunology[MESH] |Nervous System Diseases/immunology[MESH] |Patient Selection[MESH]COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harm(epmc).pdf DeepDyve Pubget Overpricing